Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Rapid Communications in Mass Spectrometry : RCM
|
November 27, 2004
Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays
Linda E Chovan, Candace Black-Schaefer, Peter J Dandliker, et al.
Journal of Pharmaceutical Sciences
|
November 10, 2006
Solid phase extraction as a faster alternative to HPLC: application to MS analysis of metabolic stability samples
Brittany L Inman, Linda E Chovan, Peter J Dandliker, et al.
Nature Reviews. Chemistry
|
April 28, 2023
Exploring new targets and chemical space with affinity selection-mass spectrometry
Renaud Prudent, D Allen Annis, Peter J Dandliker, et al.
Antimicrobial Agents and Chemotherapy
|
April 28, 2005
Mechanism of action of a novel series of naphthyridine-type ribosome inhibitors: enhancement of tRNA footprinting at the decoding site of 16S rRNA
Linus L Shen, Candace Black-Schaefer, Yingna Cai, et al.
Journal of the American Chemical Society
|
February 26, 2004
SOS-NMR: a saturation transfer NMR-based method for determining the structures of protein-ligand complexes
Philip J Hajduk, Jamey C Mack, Edward T Olejniczak, et al.
Nature
|
April 25, 2018
Nanoscale synthesis and affinity ranking
Nathan J Gesmundo, Bérengère Sauvagnat, Patrick J Curran, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 25, 2005
Synthesis and antibacterial activity of 5-methoxy- and 5-hydroxy-6-fluoro-1,8-naphthyridone-3-carboxylic acid derivatives
T Matthew Hansen, Yu-Gui Gu, Tamara M Rehm, et al.
Antiviral Chemistry & Chemotherapy
|
July 14, 2007
Pharmacokinetic enhancement of the hepatitis C virus protease inhibitors VX-950 and SCH 503034 by co-dosing with ritonavir
Dale J Kempf, Cheri Klein, Hui-Ju Chen, et al.
Nature
|
March 31, 2022
Targeting Xist with compounds that disrupt RNA structure and X inactivation
Rodrigo Aguilar, Kerrie B Spencer, Barry Kesner, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 29, 2007
Rapid hit to lead evaluation of pyrazolo[3,4-d]pyrimidin-4-one as selective and orally bioavailable mGluR1 antagonists
Xueqing Wang, Teodozyi Kolasa, Odile F El Kouhen, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Rapid Communications in Mass Spectrometry : RCM
|
November 27, 2004
Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays
Linda E Chovan, Candace Black-Schaefer, Peter J Dandliker, et al.
Journal of Pharmaceutical Sciences
|
November 10, 2006
Solid phase extraction as a faster alternative to HPLC: application to MS analysis of metabolic stability samples
Brittany L Inman, Linda E Chovan, Peter J Dandliker, et al.
Nature Reviews. Chemistry
|
April 28, 2023
Exploring new targets and chemical space with affinity selection-mass spectrometry
Renaud Prudent, D Allen Annis, Peter J Dandliker, et al.
Antimicrobial Agents and Chemotherapy
|
April 28, 2005
Mechanism of action of a novel series of naphthyridine-type ribosome inhibitors: enhancement of tRNA footprinting at the decoding site of 16S rRNA
Linus L Shen, Candace Black-Schaefer, Yingna Cai, et al.
Journal of the American Chemical Society
|
February 26, 2004
SOS-NMR: a saturation transfer NMR-based method for determining the structures of protein-ligand complexes
Philip J Hajduk, Jamey C Mack, Edward T Olejniczak, et al.
Nature
|
April 25, 2018
Nanoscale synthesis and affinity ranking
Nathan J Gesmundo, Bérengère Sauvagnat, Patrick J Curran, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 25, 2005
Synthesis and antibacterial activity of 5-methoxy- and 5-hydroxy-6-fluoro-1,8-naphthyridone-3-carboxylic acid derivatives
T Matthew Hansen, Yu-Gui Gu, Tamara M Rehm, et al.
Antiviral Chemistry & Chemotherapy
|
July 14, 2007
Pharmacokinetic enhancement of the hepatitis C virus protease inhibitors VX-950 and SCH 503034 by co-dosing with ritonavir
Dale J Kempf, Cheri Klein, Hui-Ju Chen, et al.
Nature
|
March 31, 2022
Targeting Xist with compounds that disrupt RNA structure and X inactivation
Rodrigo Aguilar, Kerrie B Spencer, Barry Kesner, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 29, 2007
Rapid hit to lead evaluation of pyrazolo[3,4-d]pyrimidin-4-one as selective and orally bioavailable mGluR1 antagonists
Xueqing Wang, Teodozyi Kolasa, Odile F El Kouhen, et al.
Page
of 3